Table 3 Biochemical parameters levels in diabetic patients and healthy control subjects (smoker and non-smoker).

From: Potential role of serum copeptin among smoker T2DM patients with emphasis to ACE I/D gene polymorphism predicting DN

Parameters

Smokers

Non-smokers

Anova

P value

DS (n = 55)

CS (n = 50)

DNS (n = 51)

CNS(n = 52)

Fasting s. glucose (mg/dL)

169.10 ± 47.64

88.30 ± 14.69a

160.86 ± 74.70b

92.37 ± 16.20a

24.23

 < 0.001

HbA1C (%)

7.49 ± 1.48

5.47 ± 0.39a

7.16 ± 1.42b

5.62 ± 0.69a

37.5

 < 0.001

Serum KIM-1 (ng/mL)

29.21 ± 12.28

28.04 ± 7.43

31.64 ± 16.52

20.29 ± 6.51a

7.8

 < 0.001

Serum Copeptin (ng/mL)

543.20 ± 114.83

478.12 ± 110.4a

596.24 ± 132.9a

466.32 ± 92.79a

11.86

 < 0.001

Serum Chol (mg/dL)

178.57 ± 42.10

127.95 ± 28.70a

180.24 ± 51.93b

137.87 ± 52.22a,b

16.9

 < 0.001

Serum TG (mg/mL)

201.51 ± 75.85

132.61 ± 67.99a,

192.29 ± 76.78

142.24 ± 66.18b

10.39

 < 0.001

uPb (ng/mg creat)

0.41 ± 0.38

0.28 ± 0.13

0.25 ± 0.47a

0.11 ± 0.098a,b

5.4

 < 0.002

eGFR (mL/min/1.73m2)

120.55 ± 41.32

130.02 ± 26.82

119.65 ± 40.36

135.24 ± 24.77a

2.5

0.059

  1. aSignificant from DS at P < 0.001.
  2. bSignificant from CS at P < 0.001.